Low Molecular Weight Trypsin-Plasmin Inhibitors Isolated from Papain Treated Urinary Trypsin Inhibitor^[*]

Summary

Papain treatment of human urinary trypsin inhibitor (UTI₆₇; mol. wt. 43,000 by SDS-polyacrylamide gel electrophoresis, specific activity 1,897 U/mg protein) produced four new protease inhibitors, which were highly purified by gel chromatography on Sephadex G-100 and isoelectric focusing. The purified inhibitors (UTI₂₆, UTI₉-I, UTI₉-II, and UTI₉-III) were shown to be homogeneous by polyacrylamide disc gel electrophoresis, and had apparent molecular weights of 26,000, 9,000, 9,000, and 9,800, respectively, by sodium dodecyl sulfate gel electrophoresis. During enzymatic degradation of UTI₆₇, the amino acid compositions changed to more basic, and the isoelectric point increased from pH 2.0 (UTI₆₇) to pHs 4.4, 5.2, 6.6, and 8.3 (UTI₂₆, UTI₉-I, UTI₉-II, and UTI₉-III), respectively. Both the parent and degraded inhibitors had anti-plasmin activity as well as antitrypsin and anti-chymotrypsin activities. Much higher anti-plasmin/anti-trypsin and anti-plasmin/anti-chymotrypsin activities were observed in the degraded inhibitors than in the parent UTI₆₇. They competitively inhibited human plasmin with Ki values of 1.13 X 10_-7 - 2.12 X 10_-6 M (H-D-Val-Leu-Lys-pNA substrate). The reactions were very fast and the active site of the inhibitors to plasmin was thought to be different from that to trypsin or chymotrypsin.

Key words

Urinary trypsin inhibitor - Enzymatic modification of inhibitor - Plasmin inhibitor

• References

• 1 Faarvang HJ. The urinary trypsin inhibitor in man (“Mingin”). Scand J Clin Lab Invest 1965; 17 (Suppl. 183) 1-78
• 2 Dillard GHL. The trypsin inhibitor of the urine in health and disease. J Lab Clin Med 1950; 36: 266-271
• 3 Toki N, Sumi H. Urinary trypsin inhibitor and urokinase activities in renal diseases. Acta Haematol (Basel) 1982; 67: 110-114
• 4 Astrup T, Alkjaer K, Soardi F. Partial purification of the trypsin inhibitor in urine. Scand J Clin Invest 1959; 11: 181-184
• 5 Shulman NR. A proteolytic inhibitor with anticoagulant activity separated from human urine and plasma. J Biol Chem 1955; 213: 655-671
• 6 Proksch GJ, Routh JI. The purification of the trypsin inhibitor from human pregnancy urine. J Lab Clin Med 1972; 79: 491-499
• 7 Hochstrasser K, Bretzel G, Feuth H, Hilla W, Lempart K. The inter-α-trypsin inhibitor as precursor of the acid stable protease inhibitors in human serum and urine. Hoppe-Seyler’s Z Physiol Chem 1976; 357: 153-162
• 8 Sumi H, Minakata K, Takada Y, Takada A. Trypsin inhibitors in human urine. J Physiol Soc Jpn 1977; 39: 53-58
• 9 Sumi H, Takada Y, Takada A. Studies on human urinary trypsin inhibitor. 1. Its modification on treatment of urine with acid. Thromb Res 1977; 11: 747-754
• 10 Sumi H. Low molecular weight inhibitor produced by protease treatment of human urinary trypsin inhibitor (UTI). Med Biol (in Japanese) 1978; 96: 307-310
• 11 Sumi H, Takada Y, Takada A. Studies on human urinary trypsin inhibitor (UTI): Some properties of UTI-I and III, and new UTIs with very low molecular weights produced by the action of several proteinases. Abstract of 17th Cong Int Soc Hematol. 631 Paris: 1978
• 12 Sumi H, Maruyama M, Mihara H, Maehara S, Toki N. Human urinary trypsin inhibitors purified by affinity chromatography on trypsin-Sepharose. Acta Haematol Jpn 1980; 44: 146-153
• 13 Toki N, Maehara S, Hayashi M, Ukai R, Sumi H. Further purification and some properties of human urinary trypsin inhibitor. Invest Urol 1980; 17: 465-469
• 14 Sumi H, Toki N. Inhibitors of the acrosomal proteinase acrosin: Human urinary trypsin inhibitor (UTI) and 4-(2-carboxyethyl) phenyl trans 4-aminomethylcyclohexanecarboxylate hydrochloride (DV-1006). Experientia 1980; 36: 1103-1104
• 15 Sumi H, Toki N. Inhibitors of acrosin and SH-protease in normal human urine. Proc Soc Exp Biol Med 1981; 167: 530-535
• 16 Deutsch DG, Mertz ET. Plasminogen: Purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096
• 17 Robbins KC, Summaria L. Human plasminogen and plasmin. In: Perlman GE, Lorand L. (Eds) Methods in Enzymology. 1970. 19 184-199 Academic Press; New York:
• 18 Claeson G, Friberger P, Knös M, Eriksson E. Method for determination of prekallikrein in plasma, glandular kallikrein, and urokinase. Haemostasis 1978; 7: 76-78
• 19 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275
• 20 Davis BJ. Disc electrophoresis. II. Method and application to human serum proteins. Ann N Y Acad Sci 1964; 121: 404-413
• 21 Weber K, Osborn M. The reliability of molecular weight determination by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem 1969; 244: 4406-4412
• 22 Vesterberg O, Svensson H. Isoelectric fractionation, analysis, and characterization of ampholytes in natural pH gradients. Acta Chem Scand 1966; 20: 820-827
• 23 Akazawa K, Sumi H, Maruyama M, Mihara H. Studies on the acid-stable protease inhibitors in human plasma, ascites and tumor fluids. The 23rd Japan Congress of Clinical Hematology, Kanazawa, Japan. 1981 (October 29-31)
• 24 Maehara S, Sumi H, Toki N. Immunochemical studies of human urinary trypsin inhibitor. Enzyme 1981; 26: 122-128
• 25 Takasugi S, Sumi H, Toki N. Effect of urinary trypsin inhibitor on experimental acute pancreatitis. Med Biol (in Japanese) 1978; 97: 261-263